PLEASANTON, Calif.--(BUSINESS WIRE)--Clarity Medical Systems, Inc. is pleased to announce the implementation
of a significant RetCam digital imaging system program in the Russian
Federation. Dmitry Medvedev, Russia’s third President, approved the
initial purchase of RetCam Systems for 42 of Russia’s 83 states. The
RetCam Systems will be used in care centers handling prematurely-born
infants at risk for eye diseases such as retinopathy of prematurity
(ROP), the leading cause of blindness in newborns.
With over 1,000 systems installed worldwide, RetCam, a wide-field
digital imaging system, has provided physicians with brilliant,
full-color images for over a decade and has set a standard in pediatric
imaging. Physicians use RetCam to create high-quality digital images of
the exterior and interior of infant eyes, allowing them to determine if
infants have, or are suspected of having, pediatric ocular diseases.
RetCam images provide objective, interpretable details of structural
ophthalmic elements for physician review and follow-up as well as being
an excellent educational tool for hospital staff and families of
newborns. For premature infants requiring long stays in healthcare
facilities, RetCam images can be compared over time to help physicians
determine progression or regression of ophthalmic diseases. In addition,
some hospitals have expanded the use of their RetCam Systems and are now
capturing digital images of all newborn eyes.
Annually, close to 10 million premature infants are born worldwide at
risk for pediatric ocular diseases. Blindness and/or partial vision
impairment greatly affects childhood development by limiting literacy,
educational achievement, social development and vocational
opportunities. On average, sight accounts for 83% of all basic knowledge
acquired, making vision impairment a serious impediment to childhood
development.
About Clarity Medical Systems, Inc.
Clarity Medical Systems, Inc., develops, manufactures and markets
advanced, pediatric ophthalmic imaging systems, guidance and informatics
tools that enhance the clinician’s ability to diagnose, manage, and
treat eye disorders. The company's RetCam product line is helping to
improve the quality of eye healthcare in pediatric populations worldwide
and is sold to leading Neonatal Intensive Care Units on a global basis.
To date, over 1,100 RetCam systems have been installed and the eyes of
more than a million children have been imaged in over 85 countries.